Histamine H1and H2Receptor Activation Stimulates ACTH and β-Endorphin Secretion by Increasing Corticotropin-Releasing Hormone in the Hypophyseal Portal Blood
作者:
Andreas Kjær,
Ulrich Knigge,
Paul M. Plotsky,
Flemming W. Bach,
Jørgen Warberg,
期刊:
Neuroendocrinology
(Karger Available online 1992)
卷期:
Volume 56,
issue 6
页码: 851-855
ISSN:0028-3835
年代: 1992
DOI:10.1159/000126316
出版商: S. Karger AG
关键词: Histamine;Histamine agonists;Histamine receptors;Adrenocorticotropic hormone;Beta-endorphin;Corticotropin-releasing hormone;Oxytocin;Hypothalamus;Pituitary portal blood
数据来源: Karger
摘要:
Histamine (HA) stimulates the release of adrenocorticotropic hormone (ACTH) and β-endorphin (β-END) via activation of central postsynaptic H1 or H2 receptors. The effect of HA is indirect and may involve the hypothalamic regulating factors corticotropin-releasing hormone (CRH), arginine vasopressin, or oxytocin (OT). We studied the effect of specific HA H1 or H2 receptor agonists on the concentration of CRH and OT in hypophyseal portal blood in urethane-anesthetized male rats. In addition we investigated the effect of the agonists on ACTH and β-END immunoreactivity in peripheral plasma in conscious male rats pretreated with antiserum to CRH. Intracerebroventricular administration of the H1 receptor agonist 2-thiazolylethylamine (2-TEA) or the H2 receptor agonist 4-methylhistamine (4-MeHA) increased the CRH concentration in pituitary portal blood by 80-90% when compared to preinfusion levels (p < 0.05). Central infusion of saline had no effect. The level of OT in the pituitary portal blood was not affected by 2-TEA or 4-MeHA when compared to saline-treated rats. Intracerebroventricular infusion of 2-TEA or 4-MeHA increased the ACTH concentration in peripheral plasma 3- or 4-fold, respectively (p < 0.01). Pretreatment with a specific CRH antiserum (abCRH) inhibited the responses by 50 and 70%, respectively (p < 0.01). Intracerebroventricular administration of 2-TEA or 4-MeHA increased the β-END immunoreactivity in peripheral plasma 3- or 2-fold, respectively (p < 0.01). These effects were inhibited by 80-90%, when rats were pretreated with abCRH (p < 0.01). We conclude that the ACTH and β-END responses to activation of central histaminergic H1 or H2 receptors are mediated at least in part by hypothalamic CRH, whereas OT does not appear to be invo
点击下载:
PDF
(1008KB)
返 回